ABBV - AbbVie Inc.
Close
178.36
0.245 0.137%
Share volume: 119,600
Last Updated: Wed 08 Jan 2025 08:29:59 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.55%
PREVIOUS CLOSE
CHG
CHG%
$178.12
0.25
0.14%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-05 | 2023-08-07 | 2023-11-06 | 2024-02-20 | 2024-05-03 | |
| Cash flow financing | -6.192 B | -3.920 B | -2.661 B | -4.449 B | 10.819 B | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 4.193 B | 6.319 B | 7.574 B | 4.753 B | 4.040 B | |
| Net income | 228.000 M | 2.013 B | 1.767 B | 812.000 M | 1.359 B | |
| Depreciation | 2.277 B | 2.540 B | 2.301 B | 2.076 B | 2.074 B | |
| Changes in inventories | 3.833 B | 4.055 B | 3.981 B | 4.099 B | 4.245 B | |
| Changes in receivables | 11.473 B | 11.491 B | 11.412 B | 11.155 B | 11.949 B | |
| Investing Cashflow | -499.000 M | -341.000 M | -369.000 M | -800.000 M | -9.588 B | |
| Net Borrowings | 50.911 B | 47.709 B | 42.915 B | 41.637 B | 51.324 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -175.000 M | -178.000 M | -219.000 M | -205.000 M | -193.000 M | |
| Cash Change | 6.722 B | 8.766 B | 13.290 B | 12.816 B | 18.069 B |